Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTRS Viatris Inc.

交易中 05-02 11:30:08 EDT

11.55

-0.08

-0.73%

最高11.73	最低11.54	成交量204.95万
今开11.68	昨收11.63	日振幅1.63%
总市值137.10亿	流通市值136.48亿	总股本11.88亿
成交额2,380万	换手率0.17%	流通股本11.82亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTRS","market":"US","secType":"STK","nameCN":"Viatris Inc.","latestPrice":11.545,"timestamp":1714663804565,"preClose":11.63,"halted":0,"volume":2049493,"delay":0,"floatShares":1182158108,"shares":1187569149,"eps":0.045571,"marketStatus":"交易中","marketStatusCode":2,"change":-0.085,"latestTime":"05-02 11:30:08 EDT","open":11.68,"high":11.73,"low":11.54,"amount":23803834.399007,"amplitude":0.016337,"askPrice":11.55,"askSize":11248,"bidPrice":11.54,"bidSize":1911,"shortable":3,"etf":0,"ttmEps":0.045571,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714680000000},"adr":0,"listingDate":1605157200000,"adjPreClose":11.63,"dividendRate":0.041576,"preHourTrading":{"tag":"盘前","latestPrice":11.69,"preClose":11.63,"latestTime":"09:29 EDT","volume":4734,"amount":55329.126804,"timestamp":1714656599999},"postHourTrading":{"tag":"盘后","latestPrice":11.65,"preClose":11.63,"latestTime":"18:49 EDT","volume":520762,"amount":6056485.48,"timestamp":1714603756069},"volumeRatio":0.708615},"requestUrl":"/m/hq/s/VTRS/tweets","defaultTab":"tweets","newsList":[{"id":"2425591658","title":"英国 Theramex 公司认为 CMA 调查不会影响 HRT 产品供应","url":"https://stock-news.laohu8.com/highlight/detail?id=2425591658","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2425591658?lang=zh_cn&edition=full","pubTime":"2024-04-06 01:39","pubTimestamp":1712338758,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月5日 - Theramex周五表示，该公司正在考虑英国竞争监督机构对该公司购买美国制药商Viatris  的两个妇女保健产品系列的欧洲权利进行的第一阶段调查所提出的问题。该公司在给路透社的一份声明中说，监管机构的决定是兼并审查过程中的正常步骤，不会影响其在英国供应现有激素替代疗法(HRT) 产品的能力。竞争与市场管理局(CMA) 前一天曾表示， (link)，由于Theramex是英国HRT市场最大的供应商之一，该交易可能导致HRT价格上涨和选择减少。监管机构称，在对该交易进行第二阶段调查之前，双方有五个工作日的时间做出回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424836139","title":"英国监管机构称 Theramex-Viatris 交易引发竞争问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2424836139","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424836139?lang=zh_cn&edition=full","pubTime":"2024-04-04 18:22","pubTimestamp":1712226130,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月4日 - 英国竞争监督机构称，Theramex公司购买Viatris公司  两个妇女保健产品系列的欧洲权利可能会导致激素替代疗法的价格上涨和选择减少。 制药商Viatris同意 (link)，于10月份将其Duphaston和Femoston系列产品的销售权出售给总部位于伦敦的Theramex公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422141524","title":"BUZZ-杰富瑞认为澳大利亚 CSL 公司每股收益下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2422141524","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422141524?lang=zh_cn&edition=full","pubTime":"2024-03-26 02:32","pubTimestamp":1711391569,"startTime":"0","endTime":"0","summary":"    3月25日 - ** Jefferies 分析师认为，CSL    Vifor 将受到 Viatris    可能于 24 财年下半年在美国市场推出仿制 Venofer 的影响。** 券商维持 CSL 338.50 澳元/股的目标价和 \"买入 \"评级** 杰富瑞预计CSL Vifor在美国销售Venofer活性药物成分的分销商利润率将低于在欧盟销售该产品的利润率。** 券商认为 CSL 26 财年的每股收益将下降 0.8** 16位分析师中有11位将该股评为 \"买入 \"或更高评级，4位评为 \"持有\"，1位评为 \"卖出\"；他们的PT中值为310.00澳元--LSEG数据** 截至上次收盘，该股今年下跌了 1","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418391850","title":"嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=2418391850","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418391850?lang=zh_cn&edition=full","pubTime":"2024-03-12 02:18","pubTimestamp":1710181116,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      3月11日 - 华尔街主要股指周一下滑，投资者在等待本周的关键通胀数据，在上周喜忧参半的就业报告之后，这些数据可能为美国联邦储备局的货币政策路径提供线索。美东时间14:02，道琼斯工业平均指数  上涨0.05%，报38,742.57点。标准普尔500指数  下跌0.16%，报5,115.28点；纳斯达克综合指数  下跌0.32%，报16,033.175点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418330118","title":"美国 FDA 拒绝批准 Viatris 用于治疗多发性硬化症的注射剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2418330118","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418330118?lang=zh_cn&edition=full","pubTime":"2024-03-11 19:06","pubTimestamp":1710155165,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社3月11日 - Viatris  和Mapi Pharma两家公司周一表示，美国食品及药物管理局已拒绝批准Viatris  和Mapi Pharma用于治疗复发性多发性硬化症的每月一次注射剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416909272","title":"Viatris Inc.2023财年实现净利润54.70百万美元，同比减少97.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416909272","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416909272?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:22","pubTimestamp":1709482964,"startTime":"0","endTime":"0","summary":"12月31日，Viatris Inc.公布财报，公告显示公司2023财年净利润为54.70百万美元，同比减少97.37%；其中营业收入为153.82亿美元，同比减少4.90%，每股基本收益为0.05美元。从资产负债表来看，Viatris Inc.总负债272.18亿美元，其中短期债务20.26亿美元，资产负债比为1.76，流动比率为1.58。机构评级：截至2023年12月31日，当前有7家机构对Viatris Inc.目标价做出预测，其中目标均价为11.67美元，其中最低目标价为10.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040022538afdd686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040022538afdd686&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415517304","title":"嗡嗡声--美国股票走势-Shift4 Payments、Chart Industries、Applied Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2415517304","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415517304?lang=zh_cn&edition=full","pubTime":"2024-02-29 03:26","pubTimestamp":1709148400,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月28日 - 华尔街主要股指周三下滑，因本周晚些时候的通胀数据将影响人们对美国联邦储备委员会何时开始降息的预期。美东时间13:38，道琼斯工业平均指数  下跌0.10%，报38933.98点。标准普尔500指数  下跌0.05%，报5075.46点；纳斯达克综合指数  下跌0.36%，报15976.84点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415796372","title":"Viatris Inc盘中异动 临近午盘急速下挫5.06%报12.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415796372","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415796372?lang=zh_cn&edition=full","pubTime":"2024-02-29 00:47","pubTimestamp":1709138878,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日00时47分，Viatris Inc股票出现异动，股价大幅下跌5.06%。截至发稿，该股报12.56美元/股，成交量1054.05万股，换手率0.88%，振幅7.29%。Viatris Inc股票所在的制药行业中，整体跌幅为1.13%。Viatris Inc公司简介：晖致医药有限公司成立于2020年11月，由专门生产专利到期药物的辉瑞全资子公司 Upjohn 和专注于仿制药和专科药物的全球制药制造商 Mylan 合并而成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022900475879159278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022900475879159278&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414326199","title":"BUZZ-Viatris 因第四季度业绩疲软而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2414326199","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414326199?lang=zh_cn&edition=full","pubTime":"2024-02-28 21:08","pubTimestamp":1709125690,"startTime":"0","endTime":"0","summary":"    2月28日 - ** Viatris   股价在盘前交易中下跌2%，报12.95美元** 该公司公布第四季度销售额为38.3亿美元，略低于分析师预计的38.7亿美元--LSEG数据 ** VTRS 季度净亏损为 7.656 亿美元，去年同期为净利润 10.1 亿美元，受运营费用增加的影响。** 该公司还预计 2024 年的利润介于每股 2.70 美元至 2.85 美元之间，低于预期中点的每股 2.81 美元。** 截至上次收盘，VTRS 今年迄今已上涨 22.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414840018","title":"Viatris Inc    预计每股收益 65 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414840018","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414840018?lang=zh_cn&edition=full","pubTime":"2024-02-26 21:43","pubTimestamp":1708955038,"startTime":"0","endTime":"0","summary":"   * Viatris Inc    将于2月28日公布截至2023年12月31日的财报，预计季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于宾夕法尼亚州卡农斯堡的公司预计营收将从去年同期的38.7亿美元增至38.7亿美元，增幅为0.1%。)   * LSEG 分析师对 Viatris Inc 的平均预期为每股收益 65 美分。* 华尔街对 Viatris Inc 的 12 个月目标价中位数为 11.00 美元，低于其最新收盘价 13.53 美元。2月26日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411270541","title":"Viatris Inc盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411270541","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411270541?lang=zh_cn&edition=full","pubTime":"2024-02-15 22:55","pubTimestamp":1708008936,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日22时55分，Viatris Inc股票出现波动，股价快速上涨5.10%。Viatris Inc股票所在的制药行业中，整体涨幅为0.23%。其相关个股中，Cardiol Therapeutics Inc、Organon & Co、Durect Corp涨幅较大，苏轩堂、Sunshine Biopharma Inc、Petros Pharmaceuticals Inc较为活跃，换手率分别为18.57%、10.83%、10.55%，振幅较大的相关个股有Cardiol Therapeutics Inc、Durect Corp、Alimera Sciences Inc，振幅分别为18.99%、12.69%、9.88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522553687e70355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522553687e70355&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403306229","title":"BUZZ-加拿大皇家银行将 Regeneron 的评级上调至 \"跑赢大盘\"，并上调预期收益率，Regeneron 再创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2403306229","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403306229?lang=zh_cn&edition=full","pubTime":"2024-01-13 00:27","pubTimestamp":1705076833,"startTime":"0","endTime":"0","summary":"    1月12日 - ** Regeneron制药公司  股价早盘最高上涨2.1%，至 935.37美元的历史高点** 如果涨势得以保持，股价将实现三日连涨** RBC Capital Markets将REGN的评级从 \"行业表现 \"上调至 \"跑赢大盘\"；将目标价从884美元上调至1076美元。** 加拿大皇家银行认为，该公司的抗炎药物 Dupixent 将在 2024 年表现强劲，超过华尔街预期。** 加拿大皇家银行称，Co's眼病药物Eylea的高剂量版本起步稳健，最近该公司在专利 ，赢得了对Viatris  生物仿制药的竞争，为 \"市场转换提供了额外的跑道\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402435790","title":"Viatris Inc盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402435790","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402435790?lang=zh_cn&edition=full","pubTime":"2024-01-11 03:12","pubTimestamp":1704913936,"startTime":"0","endTime":"0","summary":"北京时间2024年01月11日03时12分，Viatris Inc股票出现异动，股价急速拉升5.00%。Viatris Inc股票所在的制药行业中，整体涨幅为0.48%。Viatris Inc公司简介：晖致医药有限公司成立于2020年11月，由专门生产专利到期药物的辉瑞全资子公司 Upjohn 和专注于仿制药和专科药物的全球制药制造商 Mylan 合并而成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011103121787e64b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011103121787e64b0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1138400223","title":"虎氣生財 |  需不需要擔心美股超買？2024開年應關心這4件事情；分析師預測這20隻股將是今年標指成分股的贏家","url":"https://stock-news.laohu8.com/highlight/detail?id=1138400223","media":"老虎資訊HK","top":-1,"share":"https://www.laohu8.com/m/news/1138400223?lang=zh_cn&edition=full","pubTime":"2024-01-03 15:53","pubTimestamp":1704268416,"startTime":"0","endTime":"0","summary":"大型科技公司成長狀況，及美國總統大選；②分析師預測20隻股票將是2024年標指成分股的贏家。利率衍生品市場目前押注美聯儲在2024年會進行多達六次的降息，周二在市場上圍繞這樣的定價有大量討論。不過根據分析師一致預測，在未來12個月內，這兩隻股票的潛在上漲空間將超34%。","market":"us","thumbnail":"https://static.tigerbbs.com/80aa93e0f8208440a5c51972463e78d5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/80aa93e0f8208440a5c51972463e78d5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2400862275","title":"Viatris Inc盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400862275","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400862275?lang=zh_cn&edition=full","pubTime":"2024-01-03 01:37","pubTimestamp":1704217028,"startTime":"0","endTime":"0","summary":"北京时间2024年01月03日01时37分，Viatris Inc股票出现波动，股价快速上涨5.03%。Viatris Inc股票所在的制药行业中，整体涨幅为1.73%。Viatris Inc公司简介：晖致医药有限公司成立于2020年11月，由专门生产专利到期药物的辉瑞全资子公司 Upjohn 和专注于仿制药和专科药物的全球制药制造商 Mylan 合并而成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010301370987e62daf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010301370987e62daf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394751603","title":"BUZZ-美国法院对眼药诉讼案作出有利裁决后，再生元收盘上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2394751603","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2394751603?lang=zh_cn&edition=full","pubTime":"2023-12-28 06:20","pubTimestamp":1703715619,"startTime":"0","endTime":"0","summary":"(更新)    12月27日 - ** 药品生产商再生元制药公司  股价收盘上涨2.9%，报873.98美元。** 股价在常规交易中创下历史新高，报899.86美元** 西弗吉尼亚州一家法院裁定 ，REGN 在其眼科药物 Eylea 的专利诉讼案中胜诉。** Mylan 现在是 Viatris    的一部分 ** REGN 于 2022 年 8 月起诉迈兰公司，指控其拟议的 Eylea 生物仿制药侵犯了 24 项专利。** Viatris 公司由迈兰公司和辉瑞公司  的非专利品牌药业务合并而成，经营其产品组合中的仿制药和主要品牌药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2391612507","title":"更新版 1-制药商 Viatris 任命 Theodora Mistras 为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2391612507","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2391612507?lang=zh_cn&edition=full","pubTime":"2023-12-16 06:13","pubTimestamp":1702678396,"startTime":"0","endTime":"0","summary":"    路透12月15日 - 全球医疗保健公司 Viatris   周五任命 Theodora Mistras 为首席财务官，3 月 1 日起生效。该公司表示，现任首席财务官 Sanjeev Narula 将与 Mistras 密切合作，支持平稳过渡，并将于 3 月 1 日离职。Viatris 表示，Mistras 最近的职务是花旗集团全球市场医疗保健投资银行部董事总经理，拥有近二十年的领导、咨询和资本市场经验。该制药商还任命 Philippe Martin 为首席研发官，并立即生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viatris.com","stockEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":-0.026},{"period":"3month","weight":-0.0202},{"period":"6month","weight":0.2546},{"period":"1year","weight":0.2752},{"period":"ytd","weight":0.0739}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viatris Inc.于2019年2月14日在特拉华州成立。该公司是一家全球性的医疗保健公司，该公司认为他们具有独特的定位，可以弥合仿制药和品牌之间的传统鸿沟，将两者的优点结合起来，以更全面地满足全球范围内的医疗保健需求。Viatris的使命是赋能世界各地的人们在生命的每个阶段都能过上更健康的生活，它大规模地提供准入服务，目前每年为全球约10亿患者提供高质量的药物，并触及生命的所有时刻，从出生到生命的尽头，从急性病到慢性病。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.048097},{"month":2,"riseRate":0.25,"avgChangeRate":-0.100502},{"month":3,"riseRate":0,"avgChangeRate":-0.065492},{"month":4,"riseRate":0,"avgChangeRate":-0.039911},{"month":5,"riseRate":0.75,"avgChangeRate":0.07989},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.039442},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.011595},{"month":8,"riseRate":0.666667,"avgChangeRate":0.015415},{"month":9,"riseRate":0,"avgChangeRate":-0.088155},{"month":10,"riseRate":0.333333,"avgChangeRate":0.025615},{"month":11,"riseRate":0.666667,"avgChangeRate":0.014134},{"month":12,"riseRate":1,"avgChangeRate":0.100515}],"exchange":"NASDAQ","name":"Viatris Inc.","nameEN":"Viatris Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viatris Inc.(VTRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viatris Inc.,VTRS,Viatris Inc.股票,Viatris Inc.股票老虎,Viatris Inc.股票老虎国际,Viatris Inc.行情,Viatris Inc.股票行情,Viatris Inc.股价,Viatris Inc.股市,Viatris Inc.股票价格,Viatris Inc.股票交易,Viatris Inc.股票购买,Viatris Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viatris Inc.(VTRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}